COMP <GO>
MBRX vs BFRG // GROSS PROFIT MARGIN
Moleculin Biotech Inc. (NASDAQ) VS. Bullfrog AI Holdings Inc. (NASDAQ) • 15-METRIC TALLY: MBRX 1
— BFRG 1
■ METRIC PARITY
LAST: $8.72 (-0.29%) • MKT CAP: $9.2M
gross-margins
—
LAST: $0.51 (+3.88%) • MKT CAP: $9.4M
gross-margins
18.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MBRX VS. BFRG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MBRX | BFRG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | 18.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 3/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.6 | 43.4 | +1.19 | MBRX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.2M | $9.4M | -$226.1K | BFRG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MBRX REV | BFRG REV | MBRX GROSS % | BFRG GROSS % | MBRX FCF | BFRG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $116.7K | — | 18.8% | -$22.7M | -$5.5M |
| FY 2024 | $0 | $0 | — | — | -$23.9M | -$5.6M |
| FY 2023 | $0 | $65.0K | — | — | -$23.6M | -$6.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MBRX // BETA —
BFRG // BETA —